Background {#section1-2168479018805433}
==========

Canada has adopted a strategy for patient-oriented research that integrates research into the health care system and clinical practice.^[@bibr1-2168479018805433]^ Clinical trials are the gold standard for answering questions about what therapies do and do not work. Yet clinical trials in Canada and elsewhere struggle to meet enrolment goals, slowing down our ability to answer those questions around effectiveness of therapies.^[@bibr2-2168479018805433],[@bibr3-2168479018805433]^ Declining enrolment into clinical trials has been identified as a priority issue to be addressed in Canada's Strategy for Patient-Oriented Research.^[@bibr4-2168479018805433]^ There are many possible reasons for this decline in enrolment, including a lack of public awareness of clinical trials in general, lack of ready access to clinical trials, and willingness to participate by eligible patients or healthy participants.^[@bibr5-2168479018805433][@bibr6-2168479018805433][@bibr7-2168479018805433]-[@bibr8-2168479018805433]^

There is currently very little information regarding the understanding and attitudes of the Canadian public toward clinical trials. Two Canadian studies chiefly sampled patients or their significant others rather than the general public.^[@bibr9-2168479018805433],[@bibr10-2168479018805433]^ A third study included Canadians as part of a general North American survey, but the number of Canadian participants was not reported and, on communicating with the senior author, we were advised that the number of Canadians in the survey was "negligible." Consequently, those wishing to understand attitudes toward participation in clinical trials in Canada have had to rely chiefly on data from the United States and elsewhere.^[@bibr8-2168479018805433],[@bibr11-2168479018805433][@bibr12-2168479018805433]-[@bibr13-2168479018805433]^

Clinical Trials Ontario (CTO) and Clinical Trials BC^[i](#fn1-2168479018805433){ref-type="fn"}^ surveyed residents of Ontario and British Columbia to determine their awareness of clinical trials, their perceptions of the benefits and risks associated with potential participation, and their willingness and motivation to participate in a clinical trial. This survey was one component of a greater patient and public engagement strategy to help these organizations better understand reasons for participation in clinical trials and to develop mechanisms to increase patient and public engagement with and participation in clinical trials.

Methods {#section2-2168479018805433}
=======

Clinical Trials Ontario and Clinical Trials BC developed the survey and contracted with Ipsos Canada to administer the survey electronically, drawing from registered users of the i-Say online survey rewards community, operated by Ipsos.^[@bibr14-2168479018805433]^ The target sample size was 1600 panelists---800 in British Columbia and 800 in Ontario. Stratified sampling was used, based on age, gender, and region. Details of the panel construction and sampling process are available in Online Appendix 1. The survey was administered between July 28 and August 12, 2015.

The survey questions focused on respondents' awareness of and attitudes toward clinical trials; willingness to participate in a clinical trial; perceptions of the risks, benefits, and motivators for participating in a clinical trial; and the sources to which they would turn for information. The questions in the survey were adapted, with permission, from a 2013 survey conducted by the Center for Information and Study on Clinical Research Participation (CISCRP), an independent Boston-based not-for-profit organization that has conducted several American and international surveys on public perceptions of and participation in clinical research over the past several years.^[@bibr15-2168479018805433],[@bibr16-2168479018805433]^ The complete survey is available in Online Appendix 2.

The data were cleaned and deidentified by Ipsos, and provided to the research team to be analyzed. Cleaning included removal from the data set of the records of individuals who complete a survey in a much shorter time than would be anticipated by its length and those who provided the same response category for blocks of questions.

The research team conducted descriptive statistics of the survey findings. Selected questions were subjected to cross-tabulations by respondent age, gender, education, and health status. As our analyses were hypothesis generating, we did not go beyond simple cross-tabulations.

The study was approved by the University of Toronto Health Sciences Research Ethics Board.

Results {#section3-2168479018805433}
=======

The survey was completed by 1602 adults (800 in British Columbia; 802 in Ontario). Responses from the 2 provinces have been combined, as response profiles across provinces were virtually identical. The demographics of the population has been summarized in [Table 1](#table1-2168479018805433){ref-type="table"}.

###### 

Description of Survey Participants.^a^

![](10.1177_2168479018805433-table1)

                                                                                             Response     
  ------------------------------------------------------------ ----------------------------- ------------ --------
  Gender                                                       Male                          781 (49%)    49%
  Female                                                       803 (50%)                     51%          
  Other/Prefer not to answer                                   18 (1%)                                    
  Age group, y                                                 18-34                         449 (28%)    25%^b^
  35-49                                                        452 (28%)                     25%          
  50-64                                                        379 (24%)                     28%          
  ≥65                                                          322 (20%)                     22%          
  Highest education                                            High school diploma or less   321 (20%)    35%^c^
  Some university or college / or trade or technical diploma   363 (23%)                                  
  College diploma or university degree                         626 (39%)                                  
  University graduate or post-graduate degree                  244 (15%)                                  
  Professional degree                                          46 (3%)                                    
  Employment                                                   Working full time             672 (42%)    34%^d^
  Retired                                                      354 (22%)                                  
  Working part time                                            185 (12%)                                  
  Self-employed                                                127 (8%)                                   
  Homemaking/caregiving                                        74 (5%)                                    
  Studying                                                     76 (5%)                                    
  Looking for work                                             63 (4%)                                    
  Long-term disability                                         44 (3%)                                    
  Maternity/paternity leave                                    7 (\<1%)                                   
  Self-reported health                                         Excellent                     245 (15%)    N/A
  Good                                                         978 (61%)                                  
  Fair                                                         327 (20%)                                  
  Poor or very poor                                            52 (3%)                                    
  Chronic health conditions                                    None                          958 (60%)    N/A
  One                                                          362 (23%)                                  
  Two or more                                                  282 (18%)                                  
  Life-threatening illness in past?                            No                            1345 (84%)   N/A
  Yes                                                          257 (16%)                                  
  Ethnic background                                            White/Caucasian               1230 (77%)   
  Asian                                                        185 (12%)                                  
  First Nations/Indigenous                                     22 (1%)                                    
  Other (collapsed categories)                                 104 (6%)                                   
  Prefer not to answer                                         61 (4%)                                    
  Household income                                             \<\$15,000                    84 (5%)      6%
  \$15,000-\$29,999                                            182 (11%)                     12%          
  \$30,000-\$49,999                                            252 (16%)                     17%          
  \$50,000-\$74,999                                            351 (22%)                     22%          
  \$75,000-\$100,000                                           259 (16%)                     11%          
  \>\$100,000                                                  243 (15%)                     32%          
  Prefer not to answer                                         231 (14%)                                  

^a^2011 data for ethnic diversity: http://www12.statcan.gc.ca/census-recensement/2011/rt-td/Index-eng.cfm? TABID=7

2011 data for education and labor available at: <http://www12.statcan.gc.ca/census-recensement/2011/rt-td/Index-eng.cfm?TABID=8>

Census Canada 2016 data sources:

Age and gender: <http://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=109523&PRID=10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2016&THEME=115&VID=0&VNAMEE=&VNAMEF=>

Ethnic origin: <http://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=110528&PRID=10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2017&THEME=120&VID=0&VNAMEE=&VNAMEF=>

Income: <http://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=110185&PRID=10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2016&THEME=119&VID=0&VNAMEE=&VNAMEF=>

^b^ Age 20-34.

^c^ Source: <https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/hlt-fst/edu-sco/Table.cfm?Lang=E&T=11&Geo=00&View=2&Age=2>

^d^ Source: <https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/hlt-fst/lab-tra/Table.cfm?Lang=E&T=11&Geo=00>

Eleven percent of those surveyed had been invited at some time in the past to participate in a clinical trial; 6% reported someone close to them had been invited in the past. Those who had been invited were more likely to be older: 17% of respondents 65 years or older had been invited in the past to participate in a clinical trial. By contrast, 13% of those 55 to 64 years, 10% of those 35 to 54 years, and 8% of those 18 to 34 years of age had been invited in the past to participate in a clinical trial. A higher proportion (21%) of those who reported 2 or more health conditions reported having been invited in the past to participate in a clinical trial.

[Table 2](#table2-2168479018805433){ref-type="table"} summarizes respondents' knowledge and perceptions of clinical trials. Most described their knowledge of clinical trials as either somewhat (48%) or very well informed (9%). Respondents were more likely to regard themselves as very well informed if (1) they described their health as "excellent" (22%); (2) they possessed graduate or postgraduate university education (17%); or (3) they possessed a professional degree (20%). In addition, we noted that higher proportions of those who identified their gender as "other" or "prefer not to answer" reported they were very well informed (28%) or not at all informed (22%). As this was a very small group (n=18) and responses often polarized, we kept our findings in the tables but do not report further on this group.

###### 

Respondents' Knowledge and Perceptions of Clinical Trials.

![](10.1177_2168479018805433-table2)

                                              Overall, How Would You Rate Your General Knowledge of Clinical Trials?   Overall, Would You Say Your Views About Clinical Trials Are:   In Your Opinion, How Safe Are Clinical Trials?                                                                                                                           
  ------------------------------------------- ------------------------------------------------------------------------ -------------------------------------------------------------- ------------------------------------------------ ---------- ---------- ---------- ---------- ---------- ---------- --------- ---------- ---------- ---------- ---------- ---------
  Total                                       Count                                                                    148                                                            772                                              549        133        290        658        592        53         9         217        1203       171        11         
                                              9.2%                                                                     48.2%                                                          34.3%                                            8.3%       18.1%      41.1%      37.0%      3.3%       0.6%       13.5%     75.1%      10.7%      0.7%                  
  Age, y                                      18-34                                                                    449                                                            12.0%                                            48.3%      31.4%      8.2%       15.1%^a^   39.9%^a^   39.0%^a^   5.6%^a^   0.4%^a^    12.0%^b^   72.4%^b^   14.5%^b^   1.1%^b^
  35-49                                       452                                                                      10.2%                                                          44.9%                                            35.4%      9.5%       15.5%^a^   44.0%^a^   36.5%^a^   3.3%^a^    0.7%^a^   11.1%^b^   76.5%^b^   11.9%^b^   0.4%^b^    
  50-64                                       379                                                                      6.3%                                                           49.3%                                            37.5%      6.9%       19.5%^a^   38.8%^a^   40.1%^a^   1.3%^a^    0.3%^a^   12.9%^b^   79.4%^b^   7.1%^b^    0.5%^b^    
  65+                                         322                                                                      7.5%                                                           51.2%                                            32.9%      8.4%       24.2%^a^   41.3%^a^   31.1%^a^   2.5%^a^    0.9%^a^   19.9%^b^   71.7%^b^   7.8%^b^    0.6%^b^    
  Gender                                      Male                                                                     781                                                            10.6%^c^                                         48.9%^c^   32.8%^c^   7.7%^c^    19.3%^a^   42.5%^a^   35.9%^a^   2.0%^a^   0.3%^a^    14.1%^a^   76.2%^a^   9.0%^a^    0.8%^a^
  Female                                      803                                                                      7.5%^c^                                                        48.3%^c^                                         35.6%^c^   8.6%^c^    16.8%^a^   40.3%^a^   37.7%^a^   4.4%^a^    0.7%^a^   12.7%^a^   74.7%^a^   12.1%^a^   0.5%^a^    
  Other                                       18                                                                       27.8%^c^                                                       11.1%^c^                                         38.9%^c^   22.2%^c^   22.2%^a^   11.1%^a^   50.0%^a^   11.1%^a^   5.6%^a^   27.8%^a^   44.4%^a^   22.2%^a^   5.6%^a^    
  Highest education received                  ≤ High school                                                            321                                                            7.5%^b^                                          41.4%^b^   37.1%^b^   14%^b^     18.4%^b^   31.5%^b^   45.5%^b^   3.1%^b^   1.6%^b^    13.1%^b^   74.5%^b^   12.1%^b^   0.3%^b^
  Some university or college + trade school   363                                                                      6.3%^b^                                                        48.5%^b^                                         38.6%^b^   6.6%^b^    17.1%^b^   40.2%^b^   39.4%^b^   3.3%^b^    0.0%^b^   13.2%^b^   76.3%^b^   9.9%^b^    0.6%^b^    
  College or university                       626                                                                      8.1%^b^                                                        49.0%^b^                                         35.0%^b^   7.8%^b^    16.1%^b^   44.7%^b^   35.1%^b^   3.5%^b^    0.5%^b^   11.5%^b^   77.0%^b^   10.9%^b^   0.6%^b^    
  Graduate or postgraduate                    244                                                                      16.8%^b^                                                       54.1%^b^                                         23.4%^b^   5.7%^b^    23.8%^b^   44.3%^b^   28.7%^b^   2.9%^b^    0.4%^b^   18.4%^b^   70.1%^b^   10.2%^b^   1.2%^b^    
  Professional                                46                                                                       19.6%^b^                                                       52.2%^b^                                         28.3%^b^   0.0%^b^    21.7%^b^   50.0%^b^   26.1%^b^   2.2%^b^    0.0%^b^   21.7%^b^   71.7%^b^   6.5%^b^    0.0%^b^    
  Other                                       2                                                                        0.0%^b^                                                        0.0%^b^                                          50.0%^b^   50.0%^b^   0.0%^b^    0.0%^b^    50.0%^b^   50.0%^b^   0.0%^b^   0.0%^b^    50.0%^b^   0.0%^b^    50.0%^b^   
  Self-reported health                        Excellent                                                                245                                                            22.4%^b^                                         46.9%^b^   24.5%^b^   6.1%^b^    28.2%^b^   39.2%^b^   27.3%^b^   2.9%^b^   2.4%^b^    29.4%^b^   61.2%^b^   8.6%^b^    0.8%^b^
  Good                                        978                                                                      7.3%^b^                                                        49.8%^b^                                         34.6%^b^   8.4%^b^    17.0%^b^   42.4%^b^   37.2%^b^   3.3%^b^    0.1%^b^   11.6%^b^   78.2%^b^   9.9%^b^    0.3%^b^    
  Fair                                        327                                                                      5.8%^b^                                                        43.4%^b^                                         41.0%^b^   9.8%^b^    12.2%^b^   40.4%^b^   43.1%^b^   4.0%^b^    0.3%^b^   7.3%^b^    77.4%^b^   13.8%^b^   1.5%^b^    
  Poor/very poor                              52                                                                       5.8%^b^                                                        53.8%^b^                                         32.7%^b^   7.7%^b^    28.8%^b^   28.8%^b^   38.5%^b^   1.9%^b^    1.9%^b^   15.4%^b^   67.3%^b^   15.4%^b^   1.9%^b^    
  Chronic health condition                    None                                                                     958                                                            9.3%                                             46.9%      34.1%      9.7%       14.7%^b^   40.7%^b^   40.5%^b^   3.4%^b^   0.6%^b^    12.6%^a^   74.0%^a^   12.4%^a^   0.9%^a^
  One                                         362                                                                      7.5%                                                           50.3%                                            34.5%      7.7%       19.3%^b^   44.2%^b^   33.1%^b^   2.8%^b^    0.6%^b^   11.3%^a^   81.8%^a^   6.6%^a^    0.3%^a^    
  ≥ Two                                       282                                                                      11.3%                                                          50.0%                                            34.4%      4.3%       28.0%^b^   38.3%^b^   29.8%^b^   3.5%^b^    0.4%^b^   19.5%^a^   70.2%^a^   9.9%^a^    0.4%^a^    

^a^Pearson χ^2^ *P* \< .01.

^b^Pearson χ^2^ *P* = .000.

^c^Pearson χ^2^ *P* \< .05.

Overall, 59% of respondents expressed either somewhat positive (41%) or very positive (18%) views toward clinical trials. Thirty-seven percent had neither positive nor negative views and 4% had negative or strongly negative views of clinical trials. There was little variation across age and between males and females. Respondents who expressed very positive views of clinical trials included those who described their health as "excellent" (28%) or "poor or very poor" (29%), those with higher levels of education (graduate and postgraduate 24%; professional degrees 22%) and those who had 2 or more chronic health conditions (28%).

Most respondents reported that clinical trials are either "somewhat safe" (75%) or "very safe" (14%). A higher proportion of respondents aged ≥65 years reported that clinical trials were somewhat or very safe. In addition, those who described their health as "excellent," those with higher education attainment, and those with 2 or more chronic conditions were more inclined to perceive clinical trials as very safe.

The greatest concerns about participating in a clinical trial were the possibility of encountering side effects (81%) and possible risks to overall health (52%). A further 33% of respondents identified the possibility of receiving a placebo as a "risk." Twenty-one percent had concerns over possible disclosure of their private medical information. Five percent felt there were no risks to participation.

Self-assessed knowledge of clinical trials was strongly correlated with positive views about clinical trials and about the safety of clinical trials. (Pearson chi-square, *P* = .000). For example, 91% of those who felt very well informed had either very positive (57%) or somewhat positive (34%) views of clinical trials and 48% felt they were very safe. By contrast, only 19% of those who described themselves as not at all informed about clinical trials felt very (5%) or somewhat positive (14%) about clinical trials and 6% believed them to be very safe.

If given the opportunity, most respondents were either somewhat (49%) or very willing (19%) to participate in a clinical trial ([Table 3](#table3-2168479018805433){ref-type="table"}). Willingness to participate generally increased with age and with level of education. It was also greater among those with poor or very poor health, those with multiple chronic conditions, and those who had been invited before into a clinical trial, all of which were correlated with age.

###### 

Willingness to Participate in a Clinical Trial.

![](10.1177_2168479018805433-table3)

                                                       If Given the Opportunity, How Willing Would You Be to Participate in a Clinical Trial?                                                           
  ---------------------------------------------------- ---------------------------------------------------------------------------------------- ---------- ---------- ---------- ---------- ----------- ----------
  Total                                                Count                                                                                    299        789        243        78         193         
                                                       18.7%                                                                                    49.3%      15.2%      4.9%       12.0%                  
  Age                                                  18 to 34                                                                                 449        15.8%^a^   46.1%^a^   21.6%^a^   5.3%^a^     11.1%^a^
  35 to 49                                             452                                                                                      18.4%^a^   50.2%^a^   13.5%^a^   5.3%^a^    12.6%^a^    
  50 to 65                                             379                                                                                      20.8%^a^   52.8%^a^   10.3%^a^   3.4%^a^    12.7%^a^    
  65 years                                             322                                                                                      20.5%^a^   48.1%^a^   14.3%^a^   5.3%^a^    11.8%^a^    
  Gender                                               Male                                                                                     781        18.8%^a^   51.0%^a^   14.6%^a^   4.2%^a^     11.4%^a^
  Female                                               803                                                                                      18.2%^a^   48.6%^a^   15.8%^a^   5.2%^a^    12.2%^a^    
  Other                                                18                                                                                       33.3%^a^   5.6%^a^    11.1%^a^   16.7%^a^   33.3%^a^    
  Highest education received                           ≤ High school                                                                            321        17.4%^a^   43.6%^a^   18.4%^a^   5.3%^a^     15.3%^a^
  Some university or college + trade school            363                                                                                      20.9%^a^   50.7%^a^   12.4%^a^   4.1%^a^    11.8%^a^    
  College or university                                626                                                                                      16.8%^a^   50.5%^a^   15.3%^a^   5.1%^a^    12.3%^a^    
  Graduate or post-graduate                            244                                                                                      20.1%^a^   52.9%^a^   15.2%^a^   4.1%^a^    7.8%^a^     
  Professional                                         46                                                                                       28.3%^a^   43.5%^a^   13.0%^a^   8.7%^a^    6.5%^a^     
  Other                                                2                                                                                        0.0%^a^    0.0%^a^    0.0%^a^    0.0%^a^    100.0%^a^   
  Self-reported health                                 Excellent                                                                                245        27.3%^b^   40.8%^b^   17.6%^b^   6.9%^b^     7.3%^b^
  Good                                                 978                                                                                      15.4%^b^   52.6%^b^   15.0%^b^   4.2%^b^    12.8%^b^    
  Fair                                                 327                                                                                      19.3%^b^   46.5%^b^   15.6%^b^   5.5%^b^    13.1%^b^    
  Poor or very poor                                    52                                                                                       34.6%^b^   44.2%^b^   3.8%^b^    3.8%^b^    13.5%^b^    
  Chronic health conditions                            None                                                                                     958        14.2%^b^   49.3%^b^   17.1%^b^   5.6%^b^     13.8%^b^
  One                                                  362                                                                                      21.5%^b^   51.4%^b^   14.1%^b^   4.4%^b^    8.6%^b^     
  ≥ Two                                                282                                                                                      30.1%^b^   46.5%^b^   9.9%^b^    2.8%^b^    10.6%^b^    
  Invited before to participate in a clinical trial?   No                                                                                       1198       16.4%^b^   48.8%^b^   16.0%^b^   5.6%^b^     13.2%^b^
  I have                                               180                                                                                      35.6%^b^   51.1%^b^   8.3%^b^    2.2%^b^    2.8%^b^     
  Someone close to me                                  92                                                                                       23.9%^b^   50.0%^b^   10.9%^b^   2.2%^b^    13.0%^b^    
  Unsure or prefer not to answer                       132                                                                                      12.9%^b^   50.0%^b^   19.7%^b^   3.8%^b^    13.6%^b^    

^a^Pearson χ^2^ *P* \< .01.

^b^Pearson χ^2^ *P* = .000.

^c^Pearson χ^2^ *P* \< .05.

The chief circumstances that would influence respondents' participation in a clinical trial were personal in nature, including

-   if the respondent thought the treatment would help (83%) or cure them (79%),

-   if the respondent had a terminal (78%) or chronic illness (78%),

-   if there were no other medical option (78%).

Other considerations were logistical, including how far one had to travel (65%) and the time commitment (48%).

When asked to consider societal and personal benefits of participation in clinical research, respondents were more inclined to identify societal benefits of clinical trials over personal benefits ([Figure 1](#fig1-2168479018805433){ref-type="fig"}). For example, 78% indicated that participation in clinical trials may help advance science; 78% felt that it may help save or improve the lives of patients; and 64% indicated that it may improve the health care system. By way of personal benefits, 67% felt that participation may improve their own health; 47% felt that they would probably get more time and attention from medical experts; 45% felt they may also get free care or medications; 40% felt it may help them understand their disease; and 49% felt they would derive personal satisfaction from knowing that they were helping others.

![Perceived Benefits of Clinical Trial Participation.](10.1177_2168479018805433-fig1){#fig1-2168479018805433}

Advancing science and improving the health care system were identified more often among younger respondents. Improving the lives of patients was more often cited by older respondents. Compensation for participation (48%) was cited as a benefit particularly among younger respondents.

A substantial minority believed either strongly (8%) or somewhat (30%) that people who participate in clinical trials are gambling with their health. A minority also agreed either strongly (6%) or somewhat (21%) that participants in clinical trials are treated "like experimental test subjects, not people."

Family physicians (77%) and specialty physicians (55%) were the sources to which respondents would most often turn for information if considering participating in a clinical trial. This was particularly the case among older respondents ([Table 4](#table4-2168479018805433){ref-type="table"}). However, across all subgroups, family physicians were the top-ranked source to which people would turn for information. Following physicians, older respondents were more inclined to turn to more formal sources like a disease group or patient advocacy group. While still relying heavily on physicians, younger respondents were more inclined to turn to friends and family over more formal advocacy organizations. Across all age groups, the Internet was an important source of information for about one-third of respondents. Conventional media (television, newspapers, etc) and social media (Twitter, Facebook, etc) were the least frequently nominated sources of information across all groups.

###### 

If You Were Thinking About Participating in a Clinical Trial, Where Would You Turn for Information?

![](10.1177_2168479018805433-table4)

                                                                         Family MD   Specialist MD   Other HCP   Friends/Family   Disease Group or Charity   Patient Advocacy Group   Media      Internet   Social Media
  ------------------------------------------- --------------- ---------- ----------- --------------- ----------- ---------------- -------------------------- ------------------------ ---------- ---------- --------------
  Total                                       Count           1232       887         442             522         395              367                        115                      593        92         
                                              76.9%           55.4%      27.6%       32.6%           24.7%       22.9%            7.2%                       37.0%                    5.7%                  
  Age                                         18-34           449        71.5%^a^    47.0%^a^        27.2%       39.9%^a^         20.9%^b^                   18.0%^a^                 8.0%       37.6%      7.8%^c^
  35-49                                       452             74.1%^a^   50.7%^a^    25.0%           32.7%^a^    20.6%^b^         18.8%^a^                   6.0%                     36.5%      7.3%^c^    
  50-64                                       379             78.6%^a^   59.1%^a^    28.5%           30.6%^a^    28.8%^b^         24.0%^a^                   8.4%                     39.1%      4.0%^c^    
  ≥65                                         322             86.3%^a^   69.3%^a^    30.7%           24.5%^a^    30.7%^b^         34.2%^a^                   6.2%                     34.5%      2.8%^c^    
  Gender                                      Male            781        75.8%^a^    52.9%^a^        24.2%^b^    28.6%^c^         23.7%^c^                   19.3%^a^                 5.9%^c^    36.2%      4.9%
  Female                                      803             79.0%^a^   58.7%^a^    31.4%^b^        36.7%^c^    26.2%^c^         26.8%^a^                   8.3%^c^                  38.0%      6.6%       
  Other                                       18              33.3%^a^   16.7%^a^    5.6%^b^         22.2%^c^    0.0%^c^          5.6%^a^                    11.1%^c^                 27.8%      5.6%       
  Highest education received                  ≤ High school   321        73.8%^c^    46.7%^a^        27.1%       32.7%            22.4%                      18.4%                    7.2%       34.0%      7.2%
  Some university or college + trade school   363             75.5%^c^   51.8%^a^    27.3%           31.7%       23.1%            25.1%                      8.3%                     35.8%      6.3%       
  College or university                       626             79.4%^c^   58.3%^a^    28.4%           32.7%       25.4%            23.8%                      7.0%                     39.6%      5.0%       
  Graduate or post-graduate                   244             76.6%^c^   62.3%^a^    24.6%           34.8%       27.5%            23.4%                      6.6%                     35.7%      4.1%       
  Professional                                46              80.4%^c^   69.6%^a^    39.1%           26.1%       28.3%            23.9%                      4.3%                     39.1%      10.9%      
  Other                                       2               0.0%^c^    0.0%^a^     0.0%            0.0%        0.0%             0.0%                       0.0%                     50.0%      0.0%       
  Self-reported health                        Excellent       245        77.1%       55.1%           27.3%       31.4%            23.3%                      21.6%                    7.3%       32.2%      5.7%
  Good                                        978             77.9%      55.7%       29.4%           34.7%       24.5%            23.4%                      6.4%                     37.0%      5.9%       
  Fair                                        327             74.3%      53.2%       23.2%           27.2%       26.0%            21.1%                      8.9%                     39.8%      4.9%       
  Poor or very poor                           52              73.1%      63.5%       21.2%           32.7%       25.0%            30.8%                      9.6%                     42.3%      7.7%       
  Chronic Health Conditions                   None            958        74.6%^c^    50.1%^a^        26.3%       32.9%            21.4%^a^                   19.7%^c^                 6.3%       32.4%^a^   4.9%
  One                                         362             82.0%^c^   62.2%^a^    27.1%           34.0%       26.2%^a^         26.0%^c^                   7.7%                     42.3%^a^   6.1%       
  ≥ Two                                       282             78.0%^c^   64.5%^a^    32.6%           29.8%       33.7%^a^         29.8%^c^                   9.6%                     46.1%^a^   8.2%       

^a^Pearson χ^2^ *P* = .000.

^b^Pearson χ^2^ *P* \< .01.

^c^Pearson χ^2^ *P* \< .05.

Discussion {#section4-2168479018805433}
==========

Generally, Canadians regard clinical trials positively, with overall perceptions that they provide societal and personal benefit. Support for and willingness to participate in clinical trials increased with age and was greatest among those with multiple chronic health conditions, those with higher levels of education and those who had previously participated in clinical trials.

The association of willingness to participate with age is inconsistent across studies. Nelson and colleagues found a lower willingness to participate among those aged 18-34, although the effect size of age was small.^[@bibr8-2168479018805433]^ Two other studies found no difference by age,^[@bibr10-2168479018805433],\ 17^ and Trauth and colleagues found a nonmonotonic relationship in which middle-aged respondents had the greatest willingness to participate in a medical research study.^[@bibr12-2168479018805433]^

The finding that those with high-school education or less are somewhat less willing to participate in medical research is consistent with other recent surveys of the general population.^[@bibr15-2168479018805433],[@bibr17-2168479018805433]^ However, in a Canadian study of cancer patients, Jones and colleagues found a substantially lower willingness to participate among those with a college or university degree (52%) compared with those with high school or less (82%).^[@bibr10-2168479018805433]^

The positive association of prior participation with willingness to participate in research suggests that their prior participation in clinical research was a positive experience. The finding that 43% of respondents felt either not very informed or not at all informed about clinical trials affirms the need to raise public awareness about clinical trials, so individuals are able to make better informed decisions.^[@bibr12-2168479018805433]^ Indeed, initiatives are under way in the UK and in Australia to increase the public's awareness of clinical research.^[@bibr18-2168479018805433],[@bibr19-2168479018805433]^ In the UK, though, it was found that increased awareness did not translate into increased willingness to participate.^[@bibr18-2168479018805433]^

Respondents in our study were more inclined to identify societal benefits of clinical trial participation (advancing science and improving lives) and less inclined to identify personal benefits (free care and access to medical experts), as compared with the American study on which our study was modeled.^[@bibr20-2168479018805433]^ This leaning toward societal over personal benefits may, at least in part, be associated with Canada's publicly funded health care system.

Surprisingly, there is little published in the peer-reviewed literature on this topic in the context of North America or Europe. Most is in the gray literature. Our findings are overall consistent with the closest contemporaneous equivalent: the CISCRP 2015 international study of public opinion of clinical trials.^[@bibr15-2168479018805433]^ Generally, attitudes and variation across age, gender, and health were very similar. Our respondents' overall willingness to participate in research was closer to that of European respondents and less than the willingness of what the CISCRP study termed "North Americans" but which consisted almost exclusively of American respondents (Kenneth A. Getz, Tufts Center for the Study of Drug Development, personal communication, August 31, 2017).

Limitations {#section5-2168479018805433}
-----------

This study examined 2 provinces in Canada. While they represent approximately half of Canada's population, there are limitations to the generalization of our findings to other provinces. This is a start, and we hope there will be collection of similar data in other provinces. Our study measured only people's views in the abstract. When faced with an actual opportunity to participate, decisions may differ from stated attitudes. Potentially interested people may still not participate because of a number of factors, including aspects of the study protocol, inconvenience and lifestyle issues, and financial reasons.^[@bibr21-2168479018805433]^ These logistical issues were explored in only a very cursory fashion. Also, we were not able to answer detailed questions such as why a respondent who had participated in research in the past answered in our survey that they would not again. This was a hypothesis-generating study to serve as an initial step in a larger patient engagement strategy. Therefore, only simple bivariate analyses were used to examine the association of several of the questions with age, gender, and self-reported health. No multivariable regression analyses were conducted to control for covariation. A small proportion of respondents who identified as neither male nor female responded quite differently from the rest of the sample. Though small numbers precluded drawing conclusions, this warrants further study. Finally, while the sampling method attempted to reproduce a representative population, we acknowledge that respondents consisted of a nonrandom sample of the Canadian population---particularly, those who participate routinely in online surveys.

Conclusions {#section6-2168479018805433}
===========

We found generally positive attitudes toward clinical trials but considerable room for improvement in awareness and understanding of clinical trials. However, simply increasing public awareness of clinical research through the media may not increase participation.^[@bibr18-2168479018805433]^ Indeed, we found surprisingly little reliance on both conventional and social media. With all the possible sources of information available to the public these days, it is striking that physicians are, by far, the most popular sources to which people would turn for information if contemplating entering a clinical trial---particularly one's family physician. This has been observed elsewhere.^[@bibr22-2168479018805433]^ While this points to an important potential role for the clinician in helping patients wade through difficult decisions around clinical trial participation, clinicians generally have insufficient time in their patient encounters to engage on this subject.^[@bibr23-2168479018805433][@bibr24-2168479018805433]-[@bibr25-2168479018805433]^ Nor are they generally trained in how to discuss with patients critical issues like medical uncertainty (equipoise), which is a precondition for conducting a clinical trial.^[@bibr26-2168479018805433]^ Historically, since the 1979 Belmont Commission report, there have been careful attempts to distance the treating physician from the brokering of clinical trials.^[@bibr27-2168479018805433],[@bibr28-2168479018805433]^ As we move toward practice-based research, the role of the family physician and other clinicians in assisting patients with such decisions must be addressed.^[@bibr29-2168479018805433]^
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